These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 15063733)

  • 21. Regulation of the human neurotropic virus promoter by JCV-T antigen and HIV-1 tat protein.
    Chowdhury M; Taylor JP; Tada H; Rappaport J; Wong-Staal F; Amini S; Khalili K
    Oncogene; 1990 Dec; 5(12):1737-42. PubMed ID: 2178236
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human immunodeficiency virus type 1 Tat-dependent activation of an arrested RNA polymerase II elongation complex.
    Liu Y; Suñé C; Garcia-Blanco MA
    Virology; 1999 Mar; 255(2):337-46. PubMed ID: 10069959
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Repression of the human immunodeficiency virus type-1 long terminal repeat by the c-Myc oncoprotein.
    Stojanova A; Caro C; Jarjour RJ; Oster SK; Penn LZ; Germinario RJ
    J Cell Biochem; 2004 May; 92(2):400-13. PubMed ID: 15108364
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increasing the ratio of PP2A core enzyme to holoenzyme inhibits Tat-stimulated HIV-1 transcription and virus production.
    Ruediger R; Brewis N; Ohst K; Walter G
    Virology; 1997 Nov; 238(2):432-43. PubMed ID: 9400615
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The HIV-1 Tat transactivator protein: a therapeutic target?
    Fulcher AJ; Jans DA
    IUBMB Life; 2003 Dec; 55(12):669-80. PubMed ID: 14769003
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phosphorylation of the RAP74 subunit of TFIIF correlates with Tat-activated transcription of the HIV-1 long terminal repeat.
    Zhou M; Kashanchi F; Jiang H; Ge H; Brady JN
    Virology; 2000 Mar; 268(2):452-60. PubMed ID: 10704353
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transduction of the human immunodeficiency virus type 1 promoter into human chromosomal DNA by adeno-associated virus: effects on promoter activity.
    Nahreini P; Mathews MB
    Virology; 1997 Jul; 234(1):42-50. PubMed ID: 9234945
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular approaches to inhibit HIV-1 tat expression and functions.
    Grossi MP; Caputo A; Zucchini S; Bozzini R; Marconi PC; Manservigi R; Barbanti-Brodano G; Balboni PG
    Year Immunol; 1993; 7():199-204. PubMed ID: 8396820
    [No Abstract]   [Full Text] [Related]  

  • 29. HIV-1 Tat stimulates transcription complex assembly through recruitment of TBP in the absence of TAFs.
    Raha T; Cheng SW; Green MR
    PLoS Biol; 2005 Feb; 3(2):e44. PubMed ID: 15719058
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enhanced activity of human G6PD promoter transfected in HeLa cells producing high levels of HIV-1 Tat.
    Ursini MV; Lettieri T; Braddock M; Martini G
    Virology; 1993 Sep; 196(1):338-43. PubMed ID: 8356804
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Study of transactivation effect on transcription by Tat-TAR-system of human immunodeficiency virus type 1 (HIV-1) in non-lymphoid cells HEK293 and Calu-1].
    Mingaleeva RN; Chernov IP; Kopantsev EP; Stukacheva EA; Skaptsova NV; Sverdlov ED
    Mol Gen Mikrobiol Virusol; 2009; (2):11-5. PubMed ID: 19517804
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mutational analysis of the HIV-1 LTR as a promoter of negative sense transcription.
    Bentley K; Deacon N; Sonza S; Zeichner S; Churchill M
    Arch Virol; 2004 Dec; 149(12):2277-94. PubMed ID: 15338321
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Paracrine activation of the HIV-1 LTR promoter by the viral Tat protein is mechanistically similar to trans-activation within a cell.
    Verhoef K; Klein A; Berkhout B
    Virology; 1996 Nov; 225(2):316-27. PubMed ID: 8918918
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anti-termination by SIV Tat requires flexibility of the nascent TAR structure.
    Sommer P; Vartanian JP; Wachsmuth M; Henry M; Guetard D; Wain-Hobson S
    J Mol Biol; 2004 Nov; 344(1):11-28. PubMed ID: 15504399
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HIV LTR-dependent expression of Bax selectively induces apoptosis in Tat-positive cells.
    McCoubrie JE; Kendrick TS; Minchin RF
    Biochem Biophys Res Commun; 2004 Dec; 325(4):1459-64. PubMed ID: 15555592
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The HLA class II transcriptional activator blocks the function of HIV-1 Tat and inhibits viral replication.
    Accolla RS; Mazza S; De Lerma Barbaro A; De Maria A; Tosi G
    Eur J Immunol; 2002 Oct; 32(10):2783-91. PubMed ID: 12355430
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chromatin-associated regulation of HIV-1 transcription: implications for the development of therapeutic strategies.
    Quivy V; De Walque S; Van Lint C
    Subcell Biochem; 2007; 41():371-96. PubMed ID: 17484137
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Generation of a packaging cell line for prolonged large-scale production of high-titer HIV-1-based lentiviral vector.
    Ni Y; Sun S; Oparaocha I; Humeau L; Davis B; Cohen R; Binder G; Chang YN; Slepushkin V; Dropulic B
    J Gene Med; 2005 Jun; 7(6):818-34. PubMed ID: 15693055
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Activation of the human immunodeficiency virus type I long terminal repeat by 1 alpha,25-dihydroxyvitamin D3.
    Nevado J; Tenbaum SP; Castillo AI; Sánchez-Pacheco A; Aranda A
    J Mol Endocrinol; 2007 Jun; 38(6):587-601. PubMed ID: 17556530
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Influence of regulatory genes of type 1 human immunodeficiency virus on proliferation and differentiation of murine embryonic stem cells].
    Manuilova ES; Arsen'eva EL; Khaĭdarova NV; Shugurova IM; Gornostaeva SN; Inozemtseva LS; Katrukha AI; Grivennikov IA; Tarantul VZ
    Ontogenez; 2003; 34(3):204-10. PubMed ID: 12816051
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.